ConductScience.org, home

Paper1548069

Tumor necrosis factor production in patients with leprosy.

Barnes PF and 4 others. Infect Immun, 1992. Cited by 132 papers, by iCite.

Cite this record

ConductScience Library. Tumor necrosis factor production in patients with leprosy. Papers, record 1548069. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1548069

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor necrosis factor production in patients with leprosy.
PubMed
Journal
Infect Immun
PubMed
Year
1992
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
132
iCite
Relative citation ratio, by iCite
3.63
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barnes PFP F
2Chatterjee DD
3Brennan PJP J
4Rea THT H
5Modlin RLR L

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LeprosyMajor topic
Tumor Necrosis Factor-alphaMajor topic
Antigens, Bacterial
Antigens, Surface
Carbohydrate Sequence
Enzyme-Linked Immunosorbent Assay
Erythema Nodosum
Humans
In Vitro Techniques
Leprosy, Lepromatous
Leprosy, Tuberculoid
Lipopolysaccharides
Molecular Sequence Data
Mycobacterium leprae
Radioimmunoassay

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-22553NIAID NIH HHSUnited StatesR01AI022553PubMed and NIHNIH RePORTER
AI-27285NIAID NIH HHSUnited StatesR01AI027285PubMed and NIHNIH RePORTER
AI-31066NIAID NIH HHSUnited StatesR01AI031066PubMed and NIHNIH RePORTER
R22AI022553NIHNIH RePORTER
R22AI031066NIHNIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03775460Methotrexate and Prednisolone Study in Erythema Nodosum LeprosumBackground

Source ClinicalTrials.gov

Download CSV of trials

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11009681Immune complexes and complement hypercatabolism in patients with leprosy.Clin Exp Immunol1976https://conductscience.org/library/papers/1009681PubMed
2791549Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.Clin Exp Immunol1976https://conductscience.org/library/papers/791549PubMed
31718871Expression of adhesion molecules in leprosy lesions.Infect Immun1991https://conductscience.org/library/papers/1718871PubMed
41880420L-arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae.J Immunol1991https://conductscience.org/library/papers/1880420PubMed
51903393Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis.J Biol Chem1991https://conductscience.org/library/papers/1903393PubMed
61925582Defining protective responses to pathogens: cytokine profiles in leprosy lesions.Science1991https://conductscience.org/library/papers/1925582PubMed
71997652Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes.J Exp Med1991https://conductscience.org/library/papers/1997652PubMed
82015700Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.Clin Exp Immunol1991https://conductscience.org/library/papers/2015700PubMed
92108960
Predominant structural features of the cell wall arabinogalactan of Mycobacterium tuberculosis as revealed through characterization of oligoglycosyl alditol fragments by gas chromatography/mass spectrometry and by 1H and 13C NMR analyses.
J Biol Chem1990https://conductscience.org/library/papers/2108960PubMed
102110362Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2110362PubMed
112113553Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis.J Immunol1990https://conductscience.org/library/papers/2113553PubMed
122121040Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy.Am J Pathol1990https://conductscience.org/library/papers/2121040PubMed
132124240Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.J Immunol1990https://conductscience.org/library/papers/2124240PubMed
142138940Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan.Clin Exp Immunol1990https://conductscience.org/library/papers/2138940PubMed
152205576Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis.Infect Immun1990https://conductscience.org/library/papers/2205576PubMed
162211696Evidence for the nature of the link between the arabinogalactan and peptidoglycan of mycobacterial cell walls.J Biol Chem1990https://conductscience.org/library/papers/2211696PubMed
172324549Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis.J Infect Dis1990https://conductscience.org/library/papers/2324549PubMed
182503277Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages.Clin Exp Immunol1989https://conductscience.org/library/papers/2503277PubMed
192507635Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis.J Immunol1989https://conductscience.org/library/papers/2507635PubMed
202647299The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.Cell1989https://conductscience.org/library/papers/2647299PubMed

See all 42 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.

PMIDTitleJournalYearIn PapersSource
39735044Tofacitinib in Leprosy: A Novel Therapeutic Approach in Chronic Recalcitrant Type II Reactions.Cureus2024https://conductscience.org/library/papers/39735044PubMed
38940936Molecular targets in bone cancer pain: a systematic review of inflammatory cytokines.J Mol Med (Berl)2024https://conductscience.org/library/papers/38940936PubMed
38922047Human Skin as an Ex Vivo Model for Maintaining Mycobacterium leprae and Leprosy Studies.Trop Med Infect Dis2024https://conductscience.org/library/papers/38922047PubMed
38623372Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum.Dermatol Reports2024https://conductscience.org/library/papers/38623372PubMed
38371539A Cross-Sectional Study to Evaluate the Alteration of Cytokine Expression and Activation of Inflammatory Pathway in Response to NOD1 and NOD2 Signal in Leprosy.Indian J Dermatol2023https://conductscience.org/library/papers/38371539PubMed
38003746Collected Thoughts on Mycobacterial Lipoarabinomannan, a Cell Envelope Lipoglycan.Pathogens2023https://conductscience.org/library/papers/38003746PubMed
35138630Chemokine production induced by Corynebacterium pseudotuberculosis in a murine model.Braz J Microbiol2022https://conductscience.org/library/papers/35138630PubMed
32832433What is New in the Pathogenesis and Management of Erythema Nodosum Leprosum.Indian Dermatol Online J2020https://conductscience.org/library/papers/32832433PubMed
29479352The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.Front Immunol2018https://conductscience.org/library/papers/29479352PubMed
28954119Etanercept in erythema nodosum leprosum.An Bras Dermatol2017https://conductscience.org/library/papers/28954119PubMed
28885456Tumor necrosis factor alpha secreted from oral squamous cell carcinoma contributes to cancer pain and associated inflammation.Pain2017https://conductscience.org/library/papers/28885456PubMed
28348555A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.Front Immunol2017https://conductscience.org/library/papers/28348555PubMed
28162092The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy.Infect Dis Poverty2017https://conductscience.org/library/papers/28162092PubMed
27764137Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.PLoS One2016https://conductscience.org/library/papers/27764137PubMed
26913003Atenolol Reduces Leishmania major-Induced Hyperalgesia and TNF-α Without Affecting IL-1β or Keratinocyte Derived Chemokines (KC).Front Pharmacol2016https://conductscience.org/library/papers/26913003PubMed
24770503Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day.An Bras Dermatol2014https://conductscience.org/library/papers/24770503PubMed
24374776Mechanism of immunomodulatory drugs' action in the treatment of multiple myeloma.Acta Biochim Biophys Sin (Shanghai)2014https://conductscience.org/library/papers/24374776PubMed
23318436Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy.Oncogene2013https://conductscience.org/library/papers/23318436PubMed
22988457Leprosy: an overview of pathophysiology.Interdiscip Perspect Infect Dis2012https://conductscience.org/library/papers/22988457PubMed
21366421Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.Future Microbiol2011https://conductscience.org/library/papers/21366421PubMed

See all 42 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1548069

GET https://conductscience.org/api/papers/v1/1548069/references?page=2